David B. Weiner, Ph.D. - Publications

Affiliations: 
Pathology & Laboratory Medicine University of Pennsylvania, Philadelphia, PA, United States 
Area:
DNA vaccine, HIV

275 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Shore ND, Morrow MP, McMullan T, Kraynyak KA, Sylvester A, Bhatt K, Cheung J, Boyer JD, Liu L, Sacchetta B, Rosencranz S, Heath EI, Nordquist L, Cheng HH, Tagawa ST, ... ... Weiner DB, et al. CD8 T Cells Impact Rising PSA in Biochemically Relapsed Cancer Patients Using Immunotherapy Targeting Tumor-Associated Antigens. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 32208168 DOI: 10.1016/j.ymthe.2020.02.018  0.32
2015 Muthumani K, Falzarano D, Reuschel EL, Tingey C, Flingai S, Villarreal DO, Wise M, Patel A, Izmirly A, Aljuaid A, Seliga AM, Soule G, Morrow M, Kraynyak KA, Khan AS, ... ... Weiner DB, et al. A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates. Science Translational Medicine. 7: 301ra132. PMID 26290414 DOI: 10.1126/scitranslmed.aac7462  0.32
2015 Scott VL, Villarreal DO, Hutnick NA, Walters JN, Ragwan E, Bdeir K, Yan J, Sardesai NY, Finnefrock AC, Casimiro DR, Weiner DB. DNA vaccines targeting heavy chain C-terminal fragments of Clostridium botulinum neurotoxin serotypes A, B, and E induce potent humoral and cellular immunity and provide protection from lethal toxin challenge. Human Vaccines & Immunotherapeutics. 11: 1961-71. PMID 26158319 DOI: 10.1080/21645515.2015.1066051  0.32
2015 Scott VL, Patel A, Villarreal DO, Hensley SE, Ragwan E, Yan J, Sardesai NY, Rothwell PJ, Extance JP, Caproni LJ, Weiner DB. Novel synthetic plasmid and doggybone™ DNA vaccines induce neutralizing antibodies and provide protection from lethal influenza challenge in mice. Human Vaccines & Immunotherapeutics. 0. PMID 26091432 DOI: 10.1080/21645515.2015.1022008  0.32
2015 Villarreal DO, Siefert RJ, Weiner DB. Alarmin IL-33 elicits potent TB-specific cell-mediated responses. Human Vaccines & Immunotherapeutics. 11: 1954-60. PMID 26091147 DOI: 10.1080/21645515.2015.1026499  0.32
2015 Wise MC, Hutnick NA, Pollara J, Myles DJ, Williams C, Yan J, LaBranche CC, Khan AS, Sardesai NY, Montefiori D, Barnett SW, Zolla-Pazner S, Ferrari G, Weiner DB. An enhanced synthetic multi-clade DNA prime induces improved cross-clade reactive functional antibodies when combined with an adjuvanted protein boost in non-human primates. Journal of Virology. PMID 26085155 DOI: 10.1128/JVI.00652-15  0.32
2015 Kutzler MA, Wise MC, Hutnick NA, Moldoveanu Z, Hunter M, Reuter MA, Yuan S, Yan J, Ginsberg AA, Sylvester A, Pahar B, Carnathan DG, Kathuria N, Khan AS, Montefiori D, ... ... Weiner DB, et al. Chemokine-adjuvanted electroporated DNA vaccine induces substantial protection from simian immunodeficiency virus vaginal challenge. Mucosal Immunology. PMID 25943275 DOI: 10.1038/mi.2015.31  0.32
2015 Villarreal DO, Svoronos N, Wise MC, Shedlock DJ, Morrow MP, Conejo-Garcia JR, Weiner DB. Molecular adjuvant IL-33 enhances the potency of a DNA vaccine in a lethal challenge model. Vaccine. PMID 25887087 DOI: 10.1016/j.vaccine.2015.03.086  0.32
2015 Wu SJ, Villarreal DO, Shedlock DJ, Weiner DB. Synthetic DNA approach to cytomegalovirus vaccine/immune therapy. Advances in Experimental Medicine and Biology. 848: 131-48. PMID 25757619 DOI: 10.1007/978-1-4939-2432-5_7  0.32
2015 Flingai S, Plummer EM, Patel A, Shresta S, Mendoza JM, Broderick KE, Sardesai NY, Muthumani K, Weiner DB. Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy Scientific Reports. 5. DOI: 10.1038/srep12616  0.32
2015 Lee JC, Menacherry S, Diehl MC, Giffear MD, White CJ, Juba R, Bagarazzi ML, Muthumani K, Boyer J, Agarwal V, Nicoletti F, Bart S, Kim JJ, Weiner DB, Sardesai NY. Safety, bioavailability, and pharmacokinetics of VGX-1027-A novel oral anti-inflammatory drug in healthy human subjects Clinical Pharmacology in Drug Development. DOI: 10.1002/cpdd.193  0.32
2014 Latimer B, Toporovski R, Yan J, Pankhong P, Morrow MP, Khan AS, Sardesai NY, Welles SL, Jacobson JM, Weiner DB, Kutzler MA. Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine. Human Vaccines & Immunotherapeutics. 10: 2357-65. PMID 25424943 DOI: 10.4161/hv.29590  0.32
2014 Villarreal DO, Walters J, Laddy DJ, Yan J, Weiner DB. Multivalent TB vaccines targeting the esx gene family generate potent and broad cell-mediated immune responses superior to BCG. Human Vaccines & Immunotherapeutics. 10: 2188-98. PMID 25424922 DOI: 10.4161/hv.29574  0.32
2014 Baliban SM, Michael A, Shammassian B, Mudakha S, Khan AS, Cocklin S, Zentner I, Latimer BP, Bouillaut L, Hunter M, Marx P, Sardesai NY, Welles SL, Jacobson JM, Weiner DB, et al. An optimized, synthetic DNA vaccine encoding the toxin A and toxin B receptor binding domains of Clostridium difficile induces protective antibody responses in vivo. Infection and Immunity. 82: 4080-91. PMID 25024365 DOI: 10.1128/IAI.01950-14  0.32
2014 Fargnoli AS, Mu A, Katz MG, Williams RD, Margulies KB, Weiner DB, Yang S, Bridges CR. Anti-inflammatory loaded poly-lactic glycolic acid nanoparticle formulations to enhance myocardial gene transfer: an in-vitro assessment of a drug/gene combination therapeutic approach for direct injection. Journal of Translational Medicine. 12: 171. PMID 24934216 DOI: 10.1186/1479-5876-12-171  0.32
2014 Villarreal DO, Weiner DB. Interleukin 33: a switch-hitting cytokine. Current Opinion in Immunology. 28: 102-6. PMID 24762410 DOI: 10.1016/j.coi.2014.03.004  0.32
2014 Yan J, Villarreal DO, Racine T, Chu JS, Walters JN, Morrow MP, Khan AS, Sardesai NY, Kim JJ, Kobinger GP, Weiner DB. Protective immunity to H7N9 influenza viruses elicited by synthetic DNA vaccine. Vaccine. 32: 2833-42. PMID 24631084 DOI: 10.1016/j.vaccine.2014.02.038  0.32
2014 Weiner DB, Buckland B. Vaccine Technology IV: an ECI Conference held in Albufeira, Portugal from May 20 to 24, 2012. Vaccine. 32: 2763-6. PMID 24583001 DOI: 10.1016/j.vaccine.2014.02.015  0.32
2014 Fagone P, Muthumani K, Mangano K, Magro G, Meroni PL, Kim JJ, Sardesai NY, Weiner DB, Nicoletti F. VGX-1027 modulates genes involved in lipopolysaccharide-induced Toll-like receptor 4 activation and in a murine model of systemic lupus erythematosus. Immunology. 142: 594-602. PMID 24527796 DOI: 10.1111/imm.12267  0.32
2014 Villarreal DO, Wise MC, Walters JN, Reuschel EL, Choi MJ, Obeng-Adjei N, Yan J, Morrow MP, Weiner DB. Alarmin IL-33 acts as an immunoadjuvant to enhance antigen-specific tumor immunity. Cancer Research. 74: 1789-800. PMID 24448242 DOI: 10.1158/0008-5472.CAN-13-2729  0.32
2014 Ouma GO, Rodriguez E, Muthumani K, Weiner DB, Wilensky RL, Mohler ER. In vivo electroporation of constitutively expressed HIF-1α plasmid DNA improves neovascularization in a mouse model of limb ischemia. Journal of Vascular Surgery. 59: 786-93. PMID 23850058 DOI: 10.1016/j.jvs.2013.04.043  0.32
2013 Yan J, Pankhong P, Shin TH, Obeng-Adjei N, Morrow MP, Walters JN, Khan AS, Sardesai NY, Weiner DB. Highly optimized DNA vaccine targeting human telomerase reverse transcriptase stimulates potent antitumor immunity. Cancer Immunology Research. 1: 179-89. PMID 24777680 DOI: 10.1158/2326-6066.CIR-13-0001  0.32
2013 Muthumani K, Wise MC, Broderick KE, Hutnick N, Goodman J, Flingai S, Yan J, Bian CB, Mendoza J, Tingey C, Wilson C, Wojtak K, Sardesai NY, Weiner DB. HIV-1 Env DNA vaccine plus protein boost delivered by EP expands B- and T-cell responses and neutralizing phenotype in vivo. Plos One. 8: e84234. PMID 24391921 DOI: 10.1371/journal.pone.0084234  0.32
2013 Obeng-Adjei N, Hutnick NA, Yan J, Chu JS, Myles DJ, Morrow MP, Sardesai NY, Weiner DB. DNA vaccine cocktail expressing genotype A and C HBV surface and consensus core antigens generates robust cytotoxic and antibody responses in mice and Rhesus macaques. Cancer Gene Therapy. 20: 652-62. PMID 24310062 DOI: 10.1038/cgt.2013.65  0.32
2013 Flingai S, Czerwonko M, Goodman J, Kudchodkar SB, Muthumani K, Weiner DB. Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants. Frontiers in Immunology. 4: 354. PMID 24204366 DOI: 10.3389/fimmu.2013.00354  0.32
2013 Ugen K, Weiner DB. DNA vaccines onward and upward! 20 years and counting! Highlights of the DNA vaccines 2012 meeting. Human Vaccines & Immunotherapeutics. 9: 2038-40. PMID 24131943 DOI: 10.4161/hv.26628  0.32
2013 Muthumani K, Flingai S, Wise M, Tingey C, Ugen KE, Weiner DB. Optimized and enhanced DNA plasmid vector based in vivo construction of a neutralizing anti-HIV-1 envelope glycoprotein Fab. Human Vaccines & Immunotherapeutics. 9: 2253-62. PMID 24045230 DOI: 10.4161/hv.26498  0.32
2013 Obeng-Adjei N, Choo DK, Weiner DB. Hydrodynamic immunization leads to poor CD8 T-cell expansion, low frequency of memory CTLs and ineffective antiviral protection. Cancer Gene Therapy. 20: 552-63. PMID 23969886 DOI: 10.1038/cgt.2013.52  0.32
2013 Ferraro B, Talbott KT, Balakrishnan A, Cisper N, Morrow MP, Hutnick NA, Myles DJ, Shedlock DJ, Obeng-Adjei N, Yan J, Kayatani AK, Richie N, Cabrera W, Shiver R, Khan AS, ... ... Weiner DB, et al. Inducing humoral and cellular responses to multiple sporozoite and liver-stage malaria antigens using exogenous plasmid DNA. Infection and Immunity. 81: 3709-20. PMID 23897618 DOI: 10.1128/IAI.00180-13  0.32
2013 Kalams SA, Parker SD, Elizaga M, Metch B, Edupuganti S, Hural J, De Rosa S, Carter DK, Rybczyk K, Frank I, Fuchs J, Koblin B, Kim DH, Joseph P, Keefer MC, ... ... Weiner DB, et al. Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery. The Journal of Infectious Diseases. 208: 818-29. PMID 23840043 DOI: 10.1093/infdis/jit236  0.32
2013 Shedlock DJ, Aviles J, Talbott KT, Wong G, Wu SJ, Villarreal DO, Myles DJ, Croyle MA, Yan J, Kobinger GP, Weiner DB. Induction of broad cytotoxic T cells by protective DNA vaccination against Marburg and Ebola. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 1432-44. PMID 23670573 DOI: 10.1038/mt.2013.61  0.32
2013 Villarreal DO, Talbott KT, Choo DK, Shedlock DJ, Weiner DB. Synthetic DNA vaccine strategies against persistent viral infections. Expert Review of Vaccines. 12: 537-54. PMID 23659301 DOI: 10.1586/erv.13.33  0.32
2013 Kulkarni V, Rosati M, Valentin A, Ganneru B, Singh AK, Yan J, Rolland M, Alicea C, Beach RK, Zhang GM, Le Gall S, Broderick KE, Sardesai NY, Heckerman D, Mothe B, ... ... Weiner DB, et al. HIV-1 p24(gag) derived conserved element DNA vaccine increases the breadth of immune response in mice. Plos One. 8: e60245. PMID 23555935 DOI: 10.1371/journal.pone.0060245  0.32
2013 Weiner DB. RNA-based vaccination: sending a strong message. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 506-8. PMID 23449108 DOI: 10.1038/mt.2013.26  0.32
2013 Bao H, Ramanathan AA, Kawalakar O, Sundaram SG, Tingey C, Bian CB, Muruganandam N, Vijayachari P, Sardesai NY, Weiner DB, Ugen KE, Muthumani K. Nonstructural protein 2 (nsP2) of Chikungunya virus (CHIKV) enhances protective immunity mediated by a CHIKV envelope protein expressing DNA Vaccine. Viral Immunology. 26: 75-83. PMID 23409931 DOI: 10.1089/vim.2012.0061  0.32
2012 Lang Kuhs KA, Toporovski R, Yan J, Ginsberg AA, Shedlock DJ, Weiner DB. Induction of intrahepatic HCV NS4B, NS5A and NS5B-specific cellular immune responses following peripheral immunization. Plos One. 7: e52165. PMID 23284919 DOI: 10.1371/journal.pone.0052165  0.32
2012 Kathuria N, Kraynyak KA, Carnathan D, Betts M, Weiner DB, Kutzler MA. Generation of antigen-specific immunity following systemic immunization with DNA vaccine encoding CCL25 chemokine immunoadjuvant. Human Vaccines & Immunotherapeutics. 8: 1607-19. PMID 23151454 DOI: 10.4161/hv.22574  0.32
2012 Shedlock DJ, Talbott KT, Wu SJ, Wilson CM, Muthumani K, Boyer JD, Sardesai NY, Awasthi S, Weiner DB. Vaccination with synthetic constructs expressing cytomegalovirus immunogens is highly T cell immunogenic in mice. Human Vaccines & Immunotherapeutics. 8: 1668-81. PMID 23151448 DOI: 10.4161/hv.22447  0.32
2012 Reuter MA, Yuan S, Marx PA, Kutzler MA, Weiner DB, Betts MR. DNA-based HIV vaccines do not induce generalized activation in mucosal tissue T cells. Human Vaccines & Immunotherapeutics. 8: 1648-53. PMID 23111167 DOI: 10.4161/hv.22247  0.32
2012 Bagarazzi ML, Yan J, Morrow MP, Shen X, Parker RL, Lee JC, Giffear M, Pankhong P, Khan AS, Broderick KE, Knott C, Lin F, Boyer JD, Draghia-Akli R, White CJ, ... ... Weiner DB, et al. Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses. Science Translational Medicine. 4: 155ra138. PMID 23052295 DOI: 10.1126/scitranslmed.3004414  0.32
2012 Obeng-Adjei N, Choo DK, Saini J, Yan J, Pankhong P, Parikh A, Chu JS, Weiner DB. Synthetic DNA immunogen encoding hepatitis B core antigen drives immune response in liver. Cancer Gene Therapy. 19: 779-87. PMID 23037809 DOI: 10.1038/cgt.2012.61  0.32
2012 Sonnenberg GF, Monticelli LA, Alenghat T, Fung TC, Hutnick NA, Kunisawa J, Shibata N, Grunberg S, Sinha R, Zahm AM, Tardif MR, Sathaliyawala T, Kubota M, Farber DL, Collman RG, ... ... Weiner DB, et al. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science (New York, N.Y.). 336: 1321-5. PMID 22674331 DOI: 10.1126/science.1222551  0.32
2012 Hutnick NA, Myles DJ, Ferraro B, Lucke C, Lin F, Yan J, Broderick KE, Khan AS, Sardesai NY, Weiner DB. Intradermal DNA vaccination enhanced by low-current electroporation improves antigen expression and induces robust cellular and humoral immune responses. Human Gene Therapy. 23: 943-50. PMID 22650607 DOI: 10.1089/hum.2012.055  0.32
2012 Feng C, Jin J, Zou Q, Chen X, Zhou C, Wu B, Weiner DB, Wang B. Interleukin-21 inhibits humoral response to an HIV DNA vaccine by enhancing Bcl-6 and Pax-5 expression. Viral Immunology. 25: 131-40. PMID 22486304 DOI: 10.1089/vim.2011.0073  0.32
2012 Hutnick NA, Myles DJ, Hirao L, Scott VL, Ferraro B, Khan AS, Lewis MG, Miller CJ, Bett AJ, Casimiro D, Sardesai NY, Kim JJ, Shiver J, Weiner DB. An optimized SIV DNA vaccine can serve as a boost for Ad5 and provide partial protection from a high-dose SIVmac251 challenge. Vaccine. 30: 3202-8. PMID 22406458 DOI: 10.1016/j.vaccine.2012.02.069  0.32
2012 Shin TH, Pankhong P, Yan J, Khan AS, Sardesai NY, Weiner DB. Induction of robust cellular immunity against HPV6 and HPV11 in mice by DNA vaccine encoding for E6/E7 antigen. Human Vaccines & Immunotherapeutics. 8: 470-8. PMID 22336879 DOI: 10.4161/hv.19180  0.32
2012 Kalams SA, Parker S, Jin X, Elizaga M, Metch B, Wang M, Hural J, Lubeck M, Eldridge J, Cardinali M, Blattner WA, Sobieszczyk M, Suriyanon V, Kalichman A, Weiner DB, et al. Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults. Plos One. 7: e29231. PMID 22242162 DOI: 10.1371/journal.pone.0029231  0.32
2012 Mothe B, Llano A, Ibarrondo J, Zamarreño J, Schiaulini M, Miranda C, Ruiz-Riol M, Berger CT, Herrero MJ, Palou E, Plana M, Rolland M, Khatri A, Heckerman D, Pereyra F, ... ... Weiner D, et al. CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control. Plos One. 7: e29717. PMID 22238642 DOI: 10.1371/journal.pone.0029717  0.32
2012 Cox JH, Ferrari MG, Earl P, Lane JR, Jagodzinski LL, Polonis VR, Kuta EG, Boyer JD, Ratto-Kim S, Eller LA, Pham DT, Hart L, Montefiori D, Ferrari G, Parrish S, ... Weiner DB, et al. Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge. Vaccine. 30: 1830-40. PMID 22234262 DOI: 10.1016/j.vaccine.2011.12.131  0.32
2012 Lang Kuhs KA, Ginsberg AA, Yan J, Wiseman RW, Khan AS, Sardesai NY, O'Connor DH, Weiner DB. Hepatitis C virus NS3/NS4A DNA vaccine induces multiepitope T cell responses in rhesus macaques mimicking human immune responses [corrected]. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 669-78. PMID 21952169 DOI: 10.1038/mt.2011.188  0.32
2012 Ugen KE, Weiner DB. Highlights of the DNA Vaccines 2011 Meeting Human Vaccines and Immunotherapeutics. 8: 1554. DOI: 10.4161/hv.22752  0.32
2012 Weiner DB, Nabel GJ. The development of gene-based vectors for immunization Vaccines: Sixth Edition. 1232-1242. DOI: 10.1016/B978-1-4557-0090-5.00064-1  0.32
2012 Ginsberg AA, Shen X, Hutnick NA, Weiner DB. Improvement of DNA vaccines by electroporation Gene Vaccines. 2147483647: 145-162. DOI: 10.1007/978-3-7091-0439-2_7  0.32
2011 Hutnick NA, Myles DJ, Bian CB, Muthumani K, Weiner DB. Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo. Current Opinion in Virology. 1: 233-40. PMID 22440782 DOI: 10.1016/j.coviro.2011.08.003  0.32
2011 Lang Kuhs KA, Toporovski R, Ginsberg AA, Olsen AL, Shedlock DJ, Morrow MP, Yan J, Wells RG, Weiner DB. Peripheral immunization induces functional intrahepatic hepatitis C specific immunity following selective retention of vaccine-specific CD8 T cells by the liver. Human Vaccines. 7: 1326-35. PMID 22108033 DOI: 10.4161/hv.7.12.18279  0.32
2011 Hirao LA, Hokey DA, Morrow MP, Jure-Kunkel MN, Weiner DB. Immune modulation through 4-1BB enhances SIV vaccine protection in non-human primates against SIVmac251 challenge. Plos One. 6: e24250. PMID 21935390 DOI: 10.1371/journal.pone.0024250  0.32
2011 Muthumani K, Shedlock DJ, Choo DK, Fagone P, Kawalekar OU, Goodman J, Bian CB, Ramanathan AA, Atman P, Tebas P, Chattergoon MA, Choo AY, Weiner DB. HIV-mediated phosphatidylinositol 3-kinase/serine-threonine kinase activation in APCs leads to programmed death-1 ligand upregulation and suppression of HIV-specific CD8 T cells. Journal of Immunology (Baltimore, Md. : 1950). 187: 2932-43. PMID 21856939 DOI: 10.4049/jimmunol.1100594  0.32
2011 Ferraro B, Morrow MP, Hutnick NA, Shin TH, Lucke CE, Weiner DB. Clinical applications of DNA vaccines: current progress. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 53: 296-302. PMID 21765081 DOI: 10.1093/cid/cir334  0.32
2011 Ugen KE, Sardesai N, Weiner DB. DNA vaccines 2010: a gumbo of accomplishment and excitement in New Orleans. Vaccine. 29: 6721-2. PMID 21763382 DOI: 10.1016/j.vaccine.2011.07.026  0.32
2011 Belisle SE, Yin J, Shedlock DJ, Dai A, Yan J, Hirao L, Kutzler MA, Lewis MG, Andersen H, Lank SM, Karl JA, O'Connor DH, Khan A, Sardesai N, Chang J, ... ... Weiner DB, et al. Long-term programming of antigen-specific immunity from gene expression signatures in the PBMC of rhesus macaques immunized with an SIV DNA vaccine. Plos One. 6: e19681. PMID 21701683 DOI: 10.1371/journal.pone.0019681  0.32
2011 Buckland BC, Aunins JG, Jansen K, Alves PM, Weiner D. Vaccine Technology III: An ECI Conference held in Puerto Vallarta, Mexico from June 6-11, 2010 Vaccine. 29: 7115-7116. PMID 21689708 DOI: 10.1016/j.vaccine.2011.06.058  0.32
2011 Yan J, Corbitt N, Pankhong P, Shin T, Khan A, Sardesai NY, Weiner DB. Immunogenicity of a novel engineered HIV-1 clade C synthetic consensus-based envelope DNA vaccine. Vaccine. 29: 7173-81. PMID 21651948 DOI: 10.1016/j.vaccine.2011.05.076  0.32
2011 Fagone P, Shedlock DJ, Bao H, Kawalekar OU, Yan J, Gupta D, Morrow MP, Patel A, Kobinger GP, Muthumani K, Weiner DB. Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination. Gene Therapy. 18: 1070-7. PMID 21544096 DOI: 10.1038/gt.2011.59  0.32
2011 Sardesai NY, Weiner DB. Electroporation delivery of DNA vaccines: prospects for success. Current Opinion in Immunology. 23: 421-9. PMID 21530212 DOI: 10.1016/j.coi.2011.03.008  0.32
2011 Ferraro B, Cisper NJ, Talbott KT, Philipson-Weiner L, Lucke CE, Khan AS, Sardesai NY, Weiner DB. Co-delivery of PSA and PSMA DNA vaccines with electroporation induces potent immune responses. Human Vaccines. 7: 120-7. PMID 21266849 DOI: 10.4161/hv.7.0.14574  0.32
2011 Mallilankaraman K, Shedlock DJ, Bao H, Kawalekar OU, Fagone P, Ramanathan AA, Ferraro B, Stabenow J, Vijayachari P, Sundaram SG, Muruganandam N, Sarangan G, Srikanth P, Khan AS, Lewis MG, ... ... Weiner DB, et al. A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates. Plos Neglected Tropical Diseases. 5: e928. PMID 21264351 DOI: 10.1371/journal.pntd.0000928  0.32
2011 Shedlock DJ, Talbott KT, Cress C, Ferraro B, Tuyishme S, Mallilankaraman K, Cisper NJ, Morrow MP, Wu SJ, Kawalekar OU, Khan AS, Sardesai NY, Muthumani K, Shen H, Weiner DB. A highly optimized DNA vaccine confers complete protective immunity against high-dose lethal lymphocytic choriomeningitis virus challenge. Vaccine. 29: 6755-62. PMID 21238574 DOI: 10.1016/j.vaccine.2010.12.064  0.32
2011 Pillet S, Kobasa D, Meunier I, Gray M, Laddy D, Weiner DB, von Messling V, Kobinger GP. Cellular immune response in the presence of protective antibody levels correlates with protection against 1918 influenza in ferrets. Vaccine. 29: 6793-801. PMID 21211587 DOI: 10.1016/j.vaccine.2010.12.059  0.32
2011 Lin F, Shen X, McCoy JR, Mendoza JM, Yan J, Kemmerrer SV, Khan AS, Weiner DB, Broderick KE, Sardesai NY. A novel prototype device for electroporation-enhanced DNA vaccine delivery simultaneously to both skin and muscle. Vaccine. 29: 6771-80. PMID 21199706 DOI: 10.1016/j.vaccine.2010.12.057  0.32
2011 Yin J, Dai A, Lecureux J, Arango T, Kutzler MA, Yan J, Lewis MG, Khan A, Sardesai NY, Montefiore D, Ruprecht R, Weiner DB, Boyer JD. High antibody and cellular responses induced to HIV-1 clade C envelope following DNA vaccines delivered by electroporation. Vaccine. 29: 6763-70. PMID 21195801 DOI: 10.1016/j.vaccine.2010.12.055  0.32
2011 Hirao LA, Draghia-Akli R, Prigge JT, Yang M, Satishchandran A, Wu L, Hammarlund E, Khan AS, Babas T, Rhodes L, Silvera P, Slifka M, Sardesai NY, Weiner DB. Multivalent smallpox DNA vaccine delivered by intradermal electroporation drives protective immunity in nonhuman primates against lethal monkeypox challenge. The Journal of Infectious Diseases. 203: 95-102. PMID 21148501 DOI: 10.1093/infdis/jiq017  0.32
2011 Moise L, Buller RM, Schriewer J, Lee J, Frey SE, Weiner DB, Martin W, De Groot AS. VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone. Vaccine. 29: 501-11. PMID 21055490 DOI: 10.1016/j.vaccine.2010.10.064  0.32
2011 Broderick KE, Shen X, Soderholm J, Lin F, McCoy J, Khan AS, Yan J, Morrow MP, Patel A, Kobinger GP, Kemmerrer S, Weiner DB, Sardesai NY. Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device. Gene Therapy. 18: 258-65. PMID 20962869 DOI: 10.1038/gt.2010.137  0.32
2010 Morrow MP, Yan J, Pankhong P, Shedlock DJ, Lewis MG, Talbott K, Toporovski R, Khan AS, Sardesai NY, Weiner DB. IL-28B/IFN-λ3 Drives Granzyme B Loading and Significantly Increases CTL Killing Activity in Macaques. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 1714-1723. PMID 28178468 DOI: 10.1038/mt.2010.118  0.32
2010 Toporovski R, Morrow MP, Weiner DB. Interferons as potential adjuvants in prophylactic vaccines. Expert Opinion On Biological Therapy. 10: 1489-500. PMID 20836750 DOI: 10.1517/14712598.2010.521495  0.32
2010 Morrow MP, Yan J, Pankhong P, Ferraro B, Lewis MG, Khan AS, Sardesai NY, Weiner DB. Unique Th1/Th2 phenotypes induced during priming and memory phases by use of interleukin-12 (IL-12) or IL-28B vaccine adjuvants in rhesus macaques. Clinical and Vaccine Immunology : Cvi. 17: 1493-9. PMID 20685940 DOI: 10.1128/CVI.00181-10  0.32
2010 Ingolotti M, Kawalekar O, Shedlock DJ, Muthumani K, Weiner DB. DNA vaccines for targeting bacterial infections. Expert Review of Vaccines. 9: 747-63. PMID 20624048 DOI: 10.1586/erv.10.57  0.32
2010 Morrow MP, Weiner DB. DNA drugs come of age. Scientific American. 303: 48-53. PMID 20583666  0.32
2010 Morrow MP, Yan J, Pankhong P, Shedlock DJ, Lewis MG, Talbott K, Toporovski R, Khan AS, Sardesai NY, Weiner DB. IL-28B/IFN-lambda 3 drives granzyme B loading and significantly increases CTL killing activity in macaques. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 1714-23. PMID 20571540 DOI: 10.1038/mt.2010.118  0.32
2010 Hirao LA, Wu L, Satishchandran A, Khan AS, Draghia-Akli R, Finnefrock AC, Bett AJ, Betts MR, Casimiro DR, Sardesai NY, Kim JJ, Shiver JW, Weiner DB. Comparative analysis of immune responses induced by vaccination with SIV antigens by recombinant Ad5 vector or plasmid DNA in rhesus macaques. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 1568-76. PMID 20551910 DOI: 10.1038/mt.2010.112  0.32
2010 Thiboutot MM, Kannan S, Kawalekar OU, Shedlock DJ, Khan AS, Sarangan G, Srikanth P, Weiner DB, Muthumani K. Chikungunya: a potentially emerging epidemic? Plos Neglected Tropical Diseases. 4: e623. PMID 20436958 DOI: 10.1371/journal.pntd.0000623  0.32
2010 Weiner DB. RV144: old vs. new. Human Vaccines. 6: 159-61. PMID 20431335  0.32
2010 Muthumani K, Lambert VM, Kawalekar O, Heller R, Kim JJ, Weiner DB, Ugen KE. Anti-cancer activity of the HIV accessory molecule viral protein R (Vpr): Delivery as a DNA expression plasmid or biologically active peptides. Vaccine. 28: 2005-10. PMID 20188256 DOI: 10.1016/j.vaccine.2009.10.060  0.32
2010 Kraynyak KA, Kutzler MA, Cisper NJ, Khan AS, Draghia-Akli R, Sardesal NY, Lewis MG, Yan J, Weiner DB. Systemic immunization with CCL27/CTACK modulates immune responses at mucosal sites in mice and macaques. Vaccine. 28: 1942-51. PMID 20188250 DOI: 10.1016/j.vaccine.2009.10.095  0.32
2010 Weiner DB, Sardesai NY, Schmaljohn C. Introduction to DNA vaccines - Las Vegas. Vaccine. 28: 1893-6. PMID 20188243 DOI: 10.1016/j.vaccine.2010.01.052  0.32
2010 Para MF, Schouten J, Rosenkranz SL, Yu S, Weiner D, Tebas P, White CJ, Reeds D, Lertora J, Patterson KB, Daar ES, Cavert W, Brizz B. Phase I/II trial of the anti-HIV activity of mifepristone in HIV-infected subjects ACTG 5200 Journal of Acquired Immune Deficiency Syndromes. 53: 491-495. PMID 20130470 DOI: 10.1097/QAI.0b013e3181d142cb  0.32
2010 Kawalekar OU, Shedlock DJ, Weiner DB. Current strategies and limitations of HIV vaccines. Current Opinion in Investigational Drugs (London, England : 2000). 11: 192-202. PMID 20112169  0.32
2010 Shedlock DJ, Talbott KT, Morrow MP, Ferraro B, Hokey DA, Muthumani K, Weiner DB. Ki-67 staining for determination of rhesus macaque T cell proliferative responses ex vivo. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 77: 275-84. PMID 20104580 DOI: 10.1002/cyto.a.20857  0.32
2010 Kutzler MA, Kraynyak KA, Nagle SJ, Parkinson RM, Zharikova D, Chattergoon M, Maguire H, Muthumani K, Ugen K, Weiner DB. Plasmids encoding the mucosal chemokines CCL27 and CCL28 are effective adjuvants in eliciting antigen-specific immunity in vivo. Gene Therapy. 17: 72-82. PMID 19847203 DOI: 10.1038/gt.2009.112  0.32
2010 Han DJ, Weiner DB, Sin JI. DNA vaccines against infectious diseases and cancer Biomolecules and Therapeutics. 18: 1-15. DOI: 10.4062/biomolther.2010.18.1.001  0.32
2009 Shedlock DJ, Silvestri G, Weiner DB. Monkeying around with HIV vaccines: using rhesus macaques to define 'gatekeepers' for clinical trials. Nature Reviews. Immunology. 9: 717-28. PMID 19859066 DOI: 10.1038/nri2636  0.32
2009 Mueller YM, Do DH, Boyer JD, Kader M, Mattapallil JJ, Lewis MG, Weiner DB, Katsikis PD. CD8+ cell depletion of SHIV89.6P-infected macaques induces CD4+ T cell proliferation that contributes to increased viral loads. Journal of Immunology (Baltimore, Md. : 1950). 183: 5006-12. PMID 19786539 DOI: 10.4049/jimmunol.0900141  0.32
2009 Muthumani G, Laddy DJ, Sundaram SG, Fagone P, Shedlock DJ, Kannan S, Wu L, Chung CW, Lankaraman KM, Burns J, Muthumani K, Weiner DB. Co-immunization with an optimized plasmid-encoded immune stimulatory interleukin, high-mobility group box 1 protein, results in enhanced interferon-gamma secretion by antigen-specific CD8 T cells. Immunology. 128: e612-20. PMID 19740322 DOI: 10.1111/j.1365-2567.2009.03044.x  0.32
2009 Redding L, Weiner DB. DNA vaccines in veterinary use. Expert Review of Vaccines. 8: 1251-76. PMID 19722897 DOI: 10.1586/erv.09.77  0.32
2009 Apostolopoulos V, Weiner DB. Development of more efficient and effective DNA vaccines. Expert Review of Vaccines. 8: 1133-4. PMID 19722884 DOI: 10.1586/erv.09.94  0.32
2009 Yin J, Dai A, Laddy DJ, Yan J, Arango T, Khan AS, Lewis MG, Andersen H, Kutzler MA, Draghia-Akli R, Weiner DB, Boyer JD. High dose of plasmid IL-15 inhibits immune responses in an influenza non-human primates immunogenicity model. Virology. 393: 49-55. PMID 19683780 DOI: 10.1016/j.virol.2009.07.017  0.32
2009 Sonnenberg GF, Weiner DB. Manipulation of T(H)17 responses in pulmonary immunity and disease through vaccination. Human Vaccines. 5: 510-9. PMID 19617711 DOI: 10.4161/hv.5.8.8879  0.32
2009 Ramanathan MP, Kuo YC, Selling BH, Li Q, Sardesai NY, Kim JJ, Weiner DB. Development of a novel DNA SynCon tetravalent dengue vaccine that elicits immune responses against four serotypes. Vaccine. 27: 6444-53. PMID 19580892 DOI: 10.1016/j.vaccine.2009.06.061  0.32
2009 Pankhong P, Weiner DB, Ramanathan MP, Nisalak A, Kalayanarooj S, Nimmannitya S, Attatippaholkun W. Molecular genetic relationship of the 3' untranslated region among Thai dengue-3 virus, Bangkok isolates, during 1973-2000. Dna and Cell Biology. 28: 481-91. PMID 19563250 DOI: 10.1089/dna.2008.0835  0.32
2009 Kraynyak KA, Kutzler MA, Cisper NJ, Laddy DJ, Morrow MP, Waldmann TA, Weiner DB. Plasmid-encoded interleukin-15 receptor alpha enhances specific immune responses induced by a DNA vaccine in vivo. Human Gene Therapy. 20: 1143-56. PMID 19530914 DOI: 10.1089/hum.2009.025  0.32
2009 Ramanathan MP, Kutzler MA, Kuo YC, Yan J, Liu H, Shah V, Bawa A, Selling B, Sardesai NY, Kim JJ, Weiner DB. Coimmunization with an optimized IL15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccines expressing consensus JEV and WNV E DIII. Vaccine. 27: 4370-80. PMID 19497647 DOI: 10.1016/j.vaccine.2009.01.137  0.32
2009 Morrow MP, Pankhong P, Laddy DJ, Schoenly KA, Yan J, Cisper N, Weiner DB. Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity. Blood. 113: 5868-77. PMID 19304955 DOI: 10.1182/blood-2008-11-190520  0.32
2009 Thieu KP, Morrow MP, Shedlock DJ, Schoenly KA, Mallilankaraman K, Choo AY, Fagone P, Weiner DB, Muthumani K. HIV-1 Vpr: regulator of viral survival. Current Hiv Research. 7: 153-62. PMID 19275584 DOI: 10.2174/157016209787581454  0.32
2009 Muthumani K, Lambert VM, Sardesai NY, Kim JJ, Heller R, Weiner DB, Ugen KE. Analysis of the potential for HIV-1 Vpr as an anti-cancer agent. Current Hiv Research. 7: 144-52. PMID 19275583 DOI: 10.2174/157016209787581481  0.32
2009 Laddy DJ, Yan J, Khan AS, Andersen H, Cohn A, Greenhouse J, Lewis M, Manischewitz J, King LR, Golding H, Draghia-Akli R, Weiner DB. Electroporation of synthetic DNA antigens offers protection in nonhuman primates challenged with highly pathogenic avian influenza virus. Journal of Virology. 83: 4624-30. PMID 19211745 DOI: 10.1128/JVI.02335-08  0.32
2009 Yan J, Hokey DA, Morrow MP, Corbitt N, Harris K, Harris D, Weiner DB. Novel SIVmac DNA vaccines encoding Env, Pol and Gag consensus proteins elicit strong cellular immune responses in cynomolgus macaques. Vaccine. 27: 3260-6. PMID 19200811 DOI: 10.1016/j.vaccine.2009.01.065  0.32
2009 Muthumani K, Lambert VM, Shanmugam M, Thieu KP, Choo AY, Chung JC, Satishchandran A, Kim JJ, Weiner DB, Ugen KE. Anti-tumor activity mediated by protein and peptide transduction of HIV viral protein R (Vpr). Cancer Biology & Therapy. 8: 180-7. PMID 19029839  0.32
2009 Yan J, Reichenbach DK, Corbitt N, Hokey DA, Ramanathan MP, McKinney KA, Weiner DB, Sewell D. Induction of antitumor immunity in vivo following delivery of a novel HPV-16 DNA vaccine encoding an E6/E7 fusion antigen. Vaccine. 27: 431-40. PMID 19022315 DOI: 10.1016/j.vaccine.2008.10.078  0.32
2009 Morrow MP, Pankhong P, Weiner DB. Design and characterization of a plasmid vector system capable of rapid generation of antibodies of multiple isotypes and specificities. Biotechnology Letters. 31: 13-22. PMID 18777012 DOI: 10.1007/s10529-008-9826-y  0.32
2009 Hirao LA, Hokey DA, Weber J, Yan J, Boyer JD, Dai A, Anderson H, Lewis M, Jure-Kunkel MN, Weiner DB. P19-49. Modulation of vaccine induced responses through CTLA-4 and 41BB enhances protection in macaques following SIVmac251 challenge Retrovirology. 6: P369. DOI: 10.1186/1742-4690-6-S3-P369  0.32
2009 Kraynyak KA, Kutzler MA, Pahar B, Sylvester A, Yan J, Carnathan D, Khan AS, Sardesai N, Moldoveanu Z, Mestecky J, Betts MR, Marx P, Weiner DB. P19-46. Co-delivery of mucosal chemokine plasmids in a systemically delivered DNA vaccine elicits systemic and mucosal immune responses in mice and macaques Retrovirology. 6: P366. DOI: 10.1186/1742-4690-6-S3-P366  0.32
2009 Boyer JD, Yin J, Dai A, Belisle S, Hirao L, Palermo R, Hokey D, Yan J, Weiner D. P16-36. Functional genomic immune profile of SIV DNA vaccines delivered by electroporation and combined with molecular adjuvants Retrovirology. 6: P265. DOI: 10.1186/1742-4690-6-S3-P265  0.32
2009 Hirao LA, Wu L, Satishchandran A, Khan AS, Finnefrock A, Casimiro D, Shiver J, Betts MR, Sardesai NY, Weiner DB. OA05-02. Analysis of DNA compared to Ad5 vaccination, as single and mixed modalities, demonstrates robust induction of cellular immune responses in macaques Retrovirology. 6: O32. DOI: 10.1186/1742-4690-6-S3-O32  0.32
2009 Hirao LA, Wu L, Khan AS, Dai A, Karl J, Lank S, Wiseman R, O'Connor D, Watkins D, Miller N, Betts MR, Sardesai NY, Boyer JD, Weiner DB. P03-11. DNA vaccination with IL-12 lowers viral replication following SIVmac251 challenge Retrovirology. 6: P28.  0.32
2009 Morrow M, Yan J, Pankhong P, Harris K, Kahn A, Sardesai N, Weiner D. P02-02. Analysis of antigen specific degranulation potentials using IL-12 or IL-28B during HIV DNA Vaccination Retrovirology. 6: P7.  0.32
2008 Hokey DA, Yan J, Hirao LA, Dai A, Boyer JD, Jure-Kunkel MN, Weiner DB. CLTA-4 blockade in vivo promotes the generation of short-lived effector CD8 T cells and a more persistent central memory CD4 T cell response. Journal of Medical Primatology. 37: 62-8. PMID 19187432 DOI: 10.1111/j.1600-0684.2008.00324.x  0.32
2008 Abdulhaqq SA, Weiner DB. DNA vaccines: developing new strategies to enhance immune responses. Immunologic Research. 42: 219-32. PMID 19066740 DOI: 10.1007/s12026-008-8076-3  0.32
2008 Muthumani K, Choo AY, Shedlock DJ, Laddy DJ, Sundaram SG, Hirao L, Wu L, Thieu KP, Chung CW, Lankaraman KM, Tebas P, Silvestri G, Weiner DB. Human immunodeficiency virus type 1 Nef induces programmed death 1 expression through a p38 mitogen-activated protein kinase-dependent mechanism. Journal of Virology. 82: 11536-44. PMID 18799583 DOI: 10.1128/JVI.00485-08  0.32
2008 Kutzler MA, Weiner DB. DNA vaccines: ready for prime time? Nature Reviews. Genetics. 9: 776-88. PMID 18781156 DOI: 10.1038/nrg2432  0.32
2008 Lang K, Weiner DB. Immunotherapy for HCV infection: next steps. Expert Review of Vaccines. 7: 915-23. PMID 18767942 DOI: 10.1586/14760584.7.7.915  0.32
2008 Apostolopoulos V, Weiner DB, Gong J. Cancer vaccines: methods for inducing immunity. Expert Review of Vaccines. 7: 861-2. PMID 18767935 DOI: 10.1586/14760584.7.7.861  0.32
2008 Yin J, Dai A, Kutzler MA, Shen A, Lecureux J, Lewis MG, Waldmann T, Weiner DB, Boyer JD. Sustained suppression of SHIV89.6P replication in macaques by vaccine-induced CD8+ memory T cells. Aids (London, England). 22: 1739-48. PMID 18753858 DOI: 10.1097/QAD.0b013e32830efdae  0.32
2008 Demberg T, Boyer JD, Malkevich N, Patterson LJ, Venzon D, Summers EL, Kalisz I, Kalyanaraman VS, Lee EM, Weiner DB, Robert-Guroff M. Sequential priming with simian immunodeficiency virus (SIV) DNA vaccines, with or without encoded cytokines, and a replicating adenovirus-SIV recombinant followed by protein boosting does not control a pathogenic SIVmac251 mucosal challenge. Journal of Virology. 82: 10911-21. PMID 18753198 DOI: 10.1128/JVI.01129-08  0.32
2008 Lang KA, Yan J, Draghia-Akli R, Khan A, Weiner DB. Strong HCV NS3- and NS4A-specific cellular immune responses induced in mice and Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine. Vaccine. 26: 6225-31. PMID 18692108 DOI: 10.1016/j.vaccine.2008.07.052  0.32
2008 Xu R, Megati S, Roopchand V, Luckay A, Masood A, Garcia-Hand D, Rosati M, Weiner DB, Felber BK, Pavlakis GN, Sidhu MK, Eldridge JH, Egan MA. Comparative ability of various plasmid-based cytokines and chemokines to adjuvant the activity of HIV plasmid DNA vaccines. Vaccine. 26: 4819-29. PMID 18657584 DOI: 10.1016/j.vaccine.2008.06.103  0.32
2008 Weiner DB. DNA vaccines: crossing a line in the sand. Introduction to special issue. Vaccine. 26: 5073-4. PMID 18652867 DOI: 10.1016/j.vaccine.2008.07.024  0.32
2008 Shedlock DJ, Hwang D, Choo AY, Chung CW, Muthumani K, Weiner DB. HIV-1 viral genes and mitochondrial apoptosis. Apoptosis : An International Journal On Programmed Cell Death. 13: 1088-99. PMID 18622704 DOI: 10.1007/s10495-008-0239-0  0.32
2008 Laddy DJ, Yan J, Kutzler M, Kobasa D, Kobinger GP, Khan AS, Greenhouse J, Sardesai NY, Draghia-Akli R, Weiner DB. Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens. Plos One. 3: e2517. PMID 18575608 DOI: 10.1371/journal.pone.0002517  0.32
2008 Halwani R, Boyer JD, Yassine-Diab B, Haddad EK, Robinson TM, Kumar S, Parkinson R, Wu L, Sidhu MK, Phillipson-Weiner R, Pavlakis GN, Felber BK, Lewis MG, Shen A, Siliciano RF, ... Weiner DB, et al. Therapeutic vaccination with simian immunodeficiency virus (SIV)-DNA + IL-12 or IL-15 induces distinct CD8 memory subsets in SIV-infected macaques. Journal of Immunology (Baltimore, Md. : 1950). 180: 7969-79. PMID 18523260  0.32
2008 Megati S, Garcia-Hand D, Cappello S, Roopchand V, Masood A, Xu R, Luckay A, Chong SY, Rosati M, Sackitey S, Weiner DB, Felber BK, Pavlakis GN, Israel ZR, Smith LR, et al. Modifying the HIV-1 env gp160 gene to improve pDNA vaccine-elicited cell-mediated immune responses. Vaccine. 26: 5083-94. PMID 18485543 DOI: 10.1016/j.vaccine.2008.03.092  0.32
2008 Muthumani K, Lankaraman KM, Laddy DJ, Sundaram SG, Chung CW, Sako E, Wu L, Khan A, Sardesai N, Kim JJ, Vijayachari P, Weiner DB. Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus. Vaccine. 26: 5128-34. PMID 18471943 DOI: 10.1016/j.vaccine.2008.03.060  0.32
2008 Calarota SA, Dai A, Trocio JN, Weiner DB, Lori F, Lisziewicz J. IL-15 as memory T-cell adjuvant for topical HIV-1 DermaVir vaccine. Vaccine. 26: 5188-95. PMID 18462844 DOI: 10.1016/j.vaccine.2008.03.067  0.32
2008 Yan J, Harris K, Khan AS, Draghia-Akli R, Sewell D, Weiner DB. Cellular immunity induced by a novel HPV18 DNA vaccine encoding an E6/E7 fusion consensus protein in mice and rhesus macaques. Vaccine. 26: 5210-5. PMID 18455277 DOI: 10.1016/j.vaccine.2008.03.069  0.32
2008 Draghia-Akli R, Khan AS, Brown PA, Pope MA, Wu L, Hirao L, Weiner DB. Parameters for DNA vaccination using adaptive constant-current electroporation in mouse and pig models. Vaccine. 26: 5230-7. PMID 18450333 DOI: 10.1016/j.vaccine.2008.03.071  0.32
2008 Hirao LA, Wu L, Khan AS, Hokey DA, Yan J, Dai A, Betts MR, Draghia-Akli R, Weiner DB. Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques. Vaccine. 26: 3112-20. PMID 18430495 DOI: 10.1016/j.vaccine.2008.02.036  0.32
2008 Hokey DA, Johnson FB, Smith J, Weber JL, Yan J, Hirao L, Boyer JD, Lewis MG, Makedonas G, Betts MR, Weiner DB. Activation drives PD-1 expression during vaccine-specific proliferation and following lentiviral infection in macaques. European Journal of Immunology. 38: 1435-45. PMID 18389475 DOI: 10.1002/eji.200737857  0.32
2008 Calarota SA, Hokey DA, Dai A, Jure-Kunkel MN, Balimane P, Weiner DB. Augmentation of SIV DNA vaccine-induced cellular immunity by targeting the 4-1BB costimulatory molecule. Vaccine. 26: 3121-34. PMID 18336959 DOI: 10.1016/j.vaccine.2008.02.017  0.32
2008 Morrow MP, Weiner DB. Cytokines as adjuvants for improving anti-HIV responses. Aids (London, England). 22: 333-8. PMID 18195559 DOI: 10.1097/QAD.0b013e3282f42461  0.32
2008 Chattergoon MA, Muthumani K, Tamura Y, Ramanathan M, Shames JP, Saulino V, Robinson TM, Montaner LJ, Weiner DB. DR5 activation of caspase-8 induces DC maturation and immune enhancement in vivo. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 419-26. PMID 18087262 DOI: 10.1038/sj.mt.6300373  0.32
2008 Hirao LA, Wu L, Khan AS, Satishchandran A, Draghia-Akli R, Weiner DB. Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques. Vaccine. 26: 440-8. PMID 18082294 DOI: 10.1016/j.vaccine.2007.10.041  0.32
2008 Schoenly KA, Weiner DB. Human immunodeficiency virus type 1 vaccine development: recent advances in the cytotoxic T-lymphocyte platform "spotty business". Journal of Virology. 82: 3166-80. PMID 17989174 DOI: 10.1128/JVI.01634-07  0.32
2007 Boyer JD, Robinson TM, Kutzler MA, Vansant G, Hokey DA, Kumar S, Parkinson R, Wu L, Sidhu MK, Pavlakis GN, Felber BK, Brown C, Silvera P, Lewis MG, Monforte J, ... ... Weiner DB, et al. Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid. Proceedings of the National Academy of Sciences of the United States of America. 104: 18648-53. PMID 18000037 DOI: 10.1073/pnas.0709198104  0.32
2007 Jalah R, Rosati M, Kulkarni V, Patel V, Bergamaschi C, Valentin A, Zhang GM, Sidhu MK, Eldridge JH, Weiner DB, Pavlakis GN, Felber BK. Efficient systemic expression of bioactive IL-15 in mice upon delivery of optimized DNA expression plasmids. Dna and Cell Biology. 26: 827-40. PMID 17979522 DOI: 10.1089/dna.2007.0645  0.32
2007 Robinson TM, Sidhu MK, Pavlakis GN, Felber BK, Silvera P, Lewis MG, Eldridge J, Weiner DB, Boyer JD. Macaques co-immunized with SIVgag/pol-HIVenv and IL-12 plasmid have increased cellular responses. Journal of Medical Primatology. 36: 276-84. PMID 17669216 DOI: 10.1111/j.1600-0684.2007.00245.x  0.32
2007 McMurry JA, Kimball S, Lee JH, Rivera D, Martin W, Weiner DB, Kutzler M, Sherman DR, Kornfeld H, De Groot AS. Epitope-driven TB vaccine development: a streamlined approach using immuno-informatics, ELISpot assays, and HLA transgenic mice. Current Molecular Medicine. 7: 351-68. PMID 17584075 DOI: 10.2174/156652407780831584  0.32
2007 Chong SY, Egan MA, Kutzler MA, Megati S, Masood A, Roopchard V, Garcia-Hand D, Montefiori DC, Quiroz J, Rosati M, Schadeck EB, Boyer JD, Pavlakis GN, Weiner DB, Sidhu M, et al. Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques. Vaccine. 25: 4967-82. PMID 17335943 DOI: 10.1016/j.vaccine.2006.11.070  0.32
2007 Laddy DJ, Yan J, Corbitt N, Kobasa D, Kobinger GP, Weiner DB. Immunogenicity of novel consensus-based DNA vaccines against avian influenza. Vaccine. 25: 2984-9. PMID 17306909 DOI: 10.1016/j.vaccine.2007.01.063  0.32
2007 Calarota SA, Weiner DB, Lori F, Lisziewicz J. Induction of HIV-specific memory T-cell responses by topical DermaVir vaccine. Vaccine. 25: 3070-4. PMID 17292518 DOI: 10.1016/j.vaccine.2007.01.024  0.32
2007 Yan J, Yoon H, Kumar S, Ramanathan MP, Corbitt N, Kutzler M, Dai A, Boyer JD, Weiner DB. Enhanced cellular immune responses elicited by an engineered HIV-1 subtype B consensus-based envelope DNA vaccine. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 411-21. PMID 17235321 DOI: 10.1038/sj.mt.6300036  0.32
2007 von Gegerfelt AS, Rosati M, Alicea C, Valentin A, Roth P, Bear J, Franchini G, Albert PS, Bischofberger N, Boyer JD, Weiner DB, Markham P, Israel ZR, Eldridge JH, Pavlakis GN, et al. Long-lasting decrease in viremia in macaques chronically infected with simian immunodeficiency virus SIVmac251 after therapeutic DNA immunization. Journal of Virology. 81: 1972-9. PMID 17135321 DOI: 10.1128/JVI.01990-06  0.32
2006 Lori F, Weiner DB, Calarota SA, Kelly LM, Lisziewicz J. Cytokine-adjuvanted HIV-DNA vaccination strategies. Springer Seminars in Immunopathology. 28: 231-8. PMID 17053912 DOI: 10.1007/s00281-006-0047-y  0.32
2006 Weiner DB. Progress in development and testing of novel recombinant vaccine platforms for HIV. Springer Seminars in Immunopathology. 28: 195-6. PMID 17043866 DOI: 10.1007/s00281-006-0053-0  0.32
2006 Hokey DA, Weiner DB. DNA vaccines for HIV: challenges and opportunities. Springer Seminars in Immunopathology. 28: 267-79. PMID 17031649 DOI: 10.1007/s00281-006-0046-z  0.32
2006 McCray AN, Ugen KE, Muthumani K, Kim JJ, Weiner DB, Heller R. Complete regression of established subcutaneous B16 murine melanoma tumors after delivery of an HIV-1 Vpr-expressing plasmid by in vivo electroporation. Molecular Therapy : the Journal of the American Society of Gene Therapy. 14: 647-55. PMID 16950655 DOI: 10.1016/j.ymthe.2006.06.010  0.32
2006 Boyer JD, Kumar S, Robinson T, Parkinson R, Wu L, Lewis M, Watkins DI, Weiner DB. Initiation of antiretroviral therapy during chronic SIV infection leads to rapid reduction in viral loads and the level of T-cell immune response. Journal of Medical Primatology. 35: 202-9. PMID 16872283 DOI: 10.1111/j.1600-0684.2006.00179.x  0.32
2006 Kumar S, Yan J, Muthumani K, Ramanathan MP, Yoon H, Pavlakis GN, Felber BK, Sidhu M, Boyer JD, Weiner DB. Immunogenicity testing of a novel engineered HIV-1 envelope gp140 DNA vaccine construct. Dna and Cell Biology. 25: 383-92. PMID 16848679 DOI: 10.1089/dna.2006.25.383  0.32
2006 Laddy DJ, Weiner DB. From plasmids to protection: a review of DNA vaccines against infectious diseases. International Reviews of Immunology. 25: 99-123. PMID 16818367 DOI: 10.1080/08830180600785827  0.32
2006 Ugen KE, Kutzler MA, Marrero B, Westover J, Coppola D, Weiner DB, Heller R. Regression of subcutaneous B16 melanoma tumors after intratumoral delivery of an IL-15-expressing plasmid followed by in vivo electroporation. Cancer Gene Therapy. 13: 969-74. PMID 16763607 DOI: 10.1038/sj.cgt.7700973  0.32
2006 Weiner DB. Introduction to DNA vaccines issue. Vaccine. 24: 4459-60. PMID 16697504 DOI: 10.1016/j.vaccine.2006.04.007  0.32
2006 Calarota SA, Otero M, Robinson TM, Dai A, Lewis MG, Boyer JD, Weiner DB. Independence of granzyme B secretion and interferon- gamma production during acute simian immunodeficiency virus infection. The Journal of Infectious Diseases. 193: 1441-50. PMID 16619193 DOI: 10.1086/503364  0.32
2006 Muthumani K, Choo AY, Zong WX, Madesh M, Hwang DS, Premkumar A, Thieu KP, Emmanuel J, Kumar S, Thompson CB, Weiner DB. The HIV-1 Vpr and glucocorticoid receptor complex is a gain-of-function interaction that prevents the nuclear localization of PARP-1. Nature Cell Biology. 8: 170-9. PMID 16429131 DOI: 10.1038/ncb1352  0.32
2006 Schadeck EB, Sidhu M, Egan MA, Chong SY, Piacente P, Masood A, Garcia-Hand D, Cappello S, Roopchand V, Megati S, Quiroz J, Boyer JD, Felber BK, Pavlakis GN, Weiner DB, et al. A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques. Vaccine. 24: 4677-87. PMID 16288822 DOI: 10.1016/j.vaccine.2005.10.035  0.32
2006 Ramanathan MP, Chambers JA, Pankhong P, Chattergoon M, Attatippaholkun W, Dang K, Shah N, Weiner DB. Host cell killing by the West Nile Virus NS2B-NS3 proteolytic complex: NS3 alone is sufficient to recruit caspase-8-based apoptotic pathway. Virology. 345: 56-72. PMID 16243374 DOI: 10.1016/j.virol.2005.08.043  0.32
2006 Boyer JD, Maciag PC, Parkinson R, Wu L, Lewis MG, Weiner DB, Paterson Y. Rhesus macaques with high levels of vaccine induced IFN-gamma producing cells better control viral set-point following challenge with SIV239. Vaccine. 24: 4498-502. PMID 16185790 DOI: 10.1016/j.vaccine.2005.08.016  0.32
2006 Kutzler MA, Cao C, Bai Y, Dong H, Choe PY, Saulino V, McLaughlin L, Whelan A, Choo AY, Weiner DB, Ugen KE. Mapping of immune responses following wild-type and mutant ABeta42 plasmid or peptide vaccination in different mouse haplotypes and HLA Class II transgenic mice. Vaccine. 24: 4630-9. PMID 16157426 DOI: 10.1016/j.vaccine.2005.08.036  0.32
2006 Egan MA, Megati S, Roopchand V, Garcia-Hand D, Luckay A, Chong SY, Rosati M, Sackitey S, Weiner DB, Felber BK, Pavlakis GN, Israel ZR, Eldridge JH, Sidhu MK. Rational design of a plasmid DNA vaccine capable of eliciting cell-mediated immune responses to multiple HIV antigens in mice. Vaccine. 24: 4510-23. PMID 16140439 DOI: 10.1016/j.vaccine.2005.08.024  0.32
2006 Otero M, Calarota SA, Dai A, De Groot AS, Boyer JD, Weiner DB. Efficacy of novel plasmid DNA encoding vaccinia antigens in improving current smallpox vaccination strategy. Vaccine. 24: 4461-70. PMID 16137803 DOI: 10.1016/j.vaccine.2005.08.010  0.32
2005 Ramanathan MP, Chambers JA, Taylor J, Korber BT, Lee MD, Nalca A, Dang K, Pankhong P, Attatippaholkun W, Weiner DB. Expression and evolutionary analysis of West Nile virus (Merion strain). Journal of Neurovirology. 11: 544-56. PMID 16338748 DOI: 10.1080/13550280500385229  0.32
2005 Encinas JA, Janssen EM, Weiner DB, Calarota SA, Nieto D, Moll T, Carlo DJ, Moss RB. Anti-T-cell Ig and mucin domain-containing protein 1 antibody decreases TH2 airway inflammation in a mouse model of asthma. The Journal of Allergy and Clinical Immunology. 116: 1343-9. PMID 16337469 DOI: 10.1016/j.jaci.2005.08.031  0.32
2005 Choo AY, Choo DK, Kim JJ, Weiner DB. DNA vaccination in immunotherapy of cancer. Cancer Treatment and Research. 123: 137-56. PMID 16211869  0.32
2005 Egan MA, Chong SY, Megati S, Montefiori DC, Rose NF, Boyer JD, Sidhu MK, Quiroz J, Rosati M, Schadeck EB, Pavlakis GN, Weiner DB, Rose JK, Israel ZR, Udem SA, et al. Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus. Aids Research and Human Retroviruses. 21: 629-43. PMID 16060834 DOI: 10.1089/aid.2005.21.629  0.32
2005 Muthumani K, Choo AY, Hwang DS, Dayes NS, Chattergoon M, Mayilvahanan S, Thieu KP, Buckley PT, Emmanuel J, Premkumar A, Weiner DB. HIV-1 Viral protein-r (Vpr) protects against lethal superantigen challenge while maintaining homeostatic T cell levels in vivo. Molecular Therapy : the Journal of the American Society of Gene Therapy. 12: 910-21. PMID 16006193 DOI: 10.1016/j.ymthe.2005.05.009  0.32
2005 Kutzler MA, Robinson TM, Chattergoon MA, Choo DK, Choo AY, Choe PY, Ramanathan MP, Parkinson R, Kudchodkar S, Tamura Y, Sidhu M, Roopchand V, Kim JJ, Pavlakis GN, Felber BK, ... ... Weiner DB, et al. Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help. Journal of Immunology (Baltimore, Md. : 1950). 175: 112-23. PMID 15972637  0.32
2005 Muthumani K, Choo AY, Hwang DS, Premkumar A, Dayes NS, Harris C, Green DR, Wadsworth SA, Siekierka JJ, Weiner DB. HIV-1 Nef-induced FasL induction and bystander killing requires p38 MAPK activation. Blood. 106: 2059-68. PMID 15928037 DOI: 10.1182/blood-2005-03-0932  0.32
2005 Song E, Zhu P, Lee SK, Chowdhury D, Kussman S, Dykxhoorn DM, Feng Y, Palliser D, Weiner DB, Shankar P, Marasco WA, Lieberman J. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nature Biotechnology. 23: 709-17. PMID 15908939 DOI: 10.1038/nbt1101  0.32
2005 Muthumani K, Choo AY, Premkumar A, Hwang DS, Thieu KP, Desai BM, Weiner DB. Human immunodeficiency virus type 1 (HIV-1) Vpr-regulated cell death: insights into mechanism. Cell Death and Differentiation. 12: 962-70. PMID 15832179 DOI: 10.1038/sj.cdd.4401583  0.32
2005 De Groot AS, Marcon L, Bishop EA, Rivera D, Kutzler M, Weiner DB, Martin W. HIV vaccine development by computer assisted design: the GAIA vaccine. Vaccine. 23: 2136-48. PMID 15755584 DOI: 10.1016/j.vaccine.2005.01.097  0.32
2005 MacGregor RR, Boyer JD, Ugen KE, Tebas P, Higgins TJ, Baine Y, Ciccarelli RB, Ginsberg RS, Weiner DB. Plasmid vaccination of stable HIV-positive subjects on antiviral treatment results in enhanced CD8 T-cell immunity and increased control of viral "blips". Vaccine. 23: 2066-73. PMID 15755572 DOI: 10.1016/j.vaccine.2005.01.010  0.32
2005 Boyer JD, Robinson TM, Maciag PC, Peng X, Johnson RS, Pavlakis G, Lewis MG, Shen A, Siliciano R, Brown CR, Weiner DB, Paterson Y. DNA prime Listeria boost induces a cellular immune response to SIV antigens in the rhesus macaque model that is capable of limited suppression of SIV239 viral replication. Virology. 333: 88-101. PMID 15708595 DOI: 10.1016/j.virol.2004.12.026  0.32
2005 Muthumani K, Hwang DS, Choo AY, Mayilvahanan S, Dayes NS, Thieu KP, Weiner DB. HIV-1 Vpr inhibits the maturation and activation of macrophages and dendritic cells in vitro. International Immunology. 17: 103-16. PMID 15611322 DOI: 10.1093/intimm/dxh190  0.32
2004 Muthumani K, Choo AY, Hwang DS, Ugen KE, Weiner DB. HIV-1 Vpr: enhancing sensitivity of tumors to apoptosis. Current Drug Delivery. 1: 335-44. PMID 16305395  0.32
2004 Kutzler MA, Weiner DB. Developing DNA vaccines that call to dendritic cells. The Journal of Clinical Investigation. 114: 1241-4. PMID 15520855 DOI: 10.1172/JCI23467  0.32
2004 Calarota SA, Weiner DB. Approaches for the design and evaluation of HIV-1 DNA vaccines. Expert Review of Vaccines. 3: S135-49. PMID 15285712 DOI: 10.1586/14760584.3.4.S135  0.32
2004 Emini EA, Weiner DB. AIDS vaccines. Expert Review of Vaccines. 3: S1-2. PMID 15285701 DOI: 10.1586/14760584.3.4.S1  0.32
2004 Calarota SA, Weiner DB. Enhancement of human immunodeficiency virus type 1-DNA vaccine potency through incorporation of T-helper 1 molecular adjuvants. Immunological Reviews. 199: 84-99. PMID 15233728 DOI: 10.1111/j.0105-2896.2004.00150.x  0.32
2004 Muthumani K, Desai BM, Hwang DS, Choo AY, Laddy DJ, Thieu KP, Rao RG, Weiner DB. HIV-1 Vpr and anti-inflammatory activity. Dna and Cell Biology. 23: 239-47. PMID 15142381 DOI: 10.1089/104454904773819824  0.32
2004 Giri M, Ugen KE, Weiner DB. DNA vaccines against human immunodeficiency virus type 1 in the past decade. Clinical Microbiology Reviews. 17: 370-89. PMID 15084506 DOI: 10.1128/CMR.17.2.370-389.2004  0.32
2004 Muthumani K, Wadsworth SA, Dayes NS, Hwang DS, Choo AY, Abeysinghe HR, Siekierka JJ, Weiner DB. Suppression of HIV-1 viral replication and cellular pathogenesis by a novel p38/JNK kinase inhibitor. Aids (London, England). 18: 739-48. PMID 15075508 DOI: 10.1097/00002030-200403260-00004  0.32
2004 Otero M, Calarota SA, Felber B, Laddy D, Pavlakis G, Boyer JD, Weiner DB. Resiquimod is a modest adjuvant for HIV-1 gag-based genetic immunization in a mouse model. Vaccine. 22: 1782-90. PMID 15068862 DOI: 10.1016/j.vaccine.2004.01.037  0.32
2004 Chattergoon MA, Saulino V, Shames JP, Stein J, Montaner LJ, Weiner DB. Co-immunization with plasmid IL-12 generates a strong T-cell memory response in mice. Vaccine. 22: 1744-50. PMID 15068858 DOI: 10.1016/j.vaccine.2004.01.036  0.32
2004 Weiner DB. Vaccine: Introduction Vaccine. 22: 1589-1591. DOI: 10.1016/j.vaccine.2004.01.033  0.32
2003 Agadjanyan MG, Chattergoon MA, Holterman MJ, Monzavi-Karbassi B, Kim JJ, Dentchev T, Wilson D, Ayyavoo V, Montaner LJ, Kieber-Emmons T, Sekaly RP, Weiner DB. Costimulatory molecule immune enhancement in a plasmid vaccine model is regulated in part through the Ig constant-like domain of CD80/86. Journal of Immunology (Baltimore, Md. : 1950). 171: 4311-9. PMID 14530356  0.32
2003 Muthumani K, Zhang D, Dayes NS, Hwang DS, Calarota SA, Choo AY, Boyer JD, Weiner DB. Novel engineered HIV-1 East African Clade-A gp160 plasmid construct induces strong humoral and cell-mediated immune responses in vivo. Virology. 314: 134-46. PMID 14517067  0.32
2003 Calarota SA, Otero M, Hermanstyne K, Hermanstayne K, Lewis M, Rosati M, Felber BK, Pavlakis GN, Boyer JD, Weiner DB. Use of interleukin 15 to enhance interferon-gamma production by antigen-specific stimulated lymphocytes from rhesus macaques. Journal of Immunological Methods. 279: 55-67. PMID 12969547  0.32
2003 Chattergoon MA, Shames JP, Weiner DB. Engineering cross-presentation in vivo. Expert Opinion On Biological Therapy. 3: 887-94. PMID 12943447 DOI: 10.1517/14712598.3.6.887  0.32
2003 Muthumani K, Choo AY, Hwang DS, Chattergoon MA, Dayes NN, Zhang D, Lee MD, Duvvuri U, Weiner DB. Mechanism of HIV-1 viral protein R-induced apoptosis. Biochemical and Biophysical Research Communications. 304: 583-92. PMID 12729593 DOI: 10.1016/S0006-291X(03)00631-4  0.32
2003 Muthumani K, Bagarazzi M, Conway D, Hwang DS, Manson K, Ciccarelli R, Israel Z, Montefiori DC, Ugen K, Miller N, Kim J, Boyer J, Weiner DB. A Gag-Pol/Env-Rev SIV239 DNA vaccine improves CD4 counts, and reduce viral loads after pathogenic intrarectal SIV(mac)251 challenge in rhesus Macaques. Vaccine. 21: 629-37. PMID 12531331 DOI: 10.1016/S0264-410X(02)00571-6  0.32
2003 Boyer JD, Kutzler MA, Chattergoon MA, Calarota SA, Pavlakis G, Sekaly RP, MacGregor RR, Weiner DB. Engineering DNA vaccination as an approach to HIV immune therapy Clinical and Applied Immunology Reviews. 3: 183-197. DOI: 10.1016/S1529-1049(02)00158-7  0.32
2002 Boyer JD, Chattergoon M, Muthumani K, Kudchodkar S, Kim J, Bagarazzi M, Pavlakis G, Sekaly R, Weiner DB. Next generation DNA vaccines for HIV-1. Journal of Liposome Research. 12: 137-42. PMID 12604047 DOI: 10.1081/LPR-120004786  0.32
2002 Baumeister MA, Chattergoon MA, Weiner DB. Prospects for an HIV vaccine: conventional approaches and DNA immunization. Biotechnology & Genetic Engineering Reviews. 19: 205-42. PMID 12520879  0.32
2002 Yang JS, Ramanathan MP, Muthumani K, Choo AY, Jin SH, Yu QC, Hwang DS, Choo DK, Lee MD, Dang K, Tang W, Kim JJ, Weiner DB. Induction of inflammation by West Nile virus capsid through the caspase-9 apoptotic pathway. Emerging Infectious Diseases. 8: 1379-84. PMID 12498651 DOI: 10.3201/eid0812.020224  0.32
2002 MacGregor RR, Ginsberg R, Ugen KE, Baine Y, Kang CU, Tu XM, Higgins T, Weiner DB, Boyer JD. T-cell responses induced in normal volunteers immunized with a DNA-based vaccine containing HIV-1 env and rev. Aids (London, England). 16: 2137-43. PMID 12409734 DOI: 10.1097/00002030-200211080-00005  0.32
2002 Gómez-Román VR, Cao C, Bai Y, Santamaría H, Acero G, Manoutcharian K, Weiner DB, Ugen KE, Gevorkian G. Phage-displayed mimotopes recognizing a biologically active anti-HIV-1 gp120 murine monoclonal antibody. Journal of Acquired Immune Deficiency Syndromes (1999). 31: 147-53. PMID 12394792  0.32
2002 Ramanathan MP, Curley E, Su M, Chambers JA, Weiner DB. Carboxyl terminus of hVIP/mov34 is critical for HIV-1-Vpr interaction and glucocorticoid-mediated signaling. The Journal of Biological Chemistry. 277: 47854-60. PMID 12237292 DOI: 10.1074/jbc.M203905200  0.32
2002 Muthumani K, Zhang D, Hwang DS, Kudchodkar S, Dayes NS, Desai BM, Malik AS, Yang JS, Chattergoon MA, Maguire HC, Weiner DB. Adenovirus encoding HIV-1 Vpr activates caspase 9 and induces apoptotic cell death in both p53 positive and negative human tumor cell lines. Oncogene. 21: 4613-25. PMID 12096338 DOI: 10.1038/sj.onc.1205549  0.32
2002 Chattergoon MA, Maguire HH, Robinson TM, Serrano E, Boyer JD, Weiner DB. Plasmid immunization primes unique DTH responses to HIV-1MN envelope epitopes as compared to recombinant protein vaccination. Hybridoma and Hybridomics. 21: 117-22. PMID 12031101 DOI: 10.1089/153685902317401717  0.32
2002 Muthumani K, Kudchodkar S, Zhang D, Bagarazzi ML, Kim JJ, Boyer JD, Ayyavoo V, Pavlakis GN, Weiner DB. Issues for improving multiplasmid DNA vaccines for HIV-1. Vaccine. 20: 1999-2003. PMID 11983262 DOI: 10.1016/S0264-410X(02)00086-5  0.32
2002 Boyer JD, Nath B, Schumann K, Curley E, Manson K, Kim J, Weiner DB. IL-4 increases Simian immunodeficiency virus replication despite enhanced SIV immune responses in infected rhesus macaques. International Journal For Parasitology. 32: 543-50. PMID 11943227 DOI: 10.1016/S0020-7519(01)00355-1  0.32
2001 Dickey CA, Morgan DG, Kudchodkar S, Weiner DB, Bai Y, Cao C, Gordon MN, Ugen KE. Duration and specificity of humoral immune responses in mice vaccinated with the Alzheimer's disease-associated beta-amyloid 1-42 peptide. Dna and Cell Biology. 20: 723-9. PMID 11788050 DOI: 10.1089/10445490152717587  0.32
2001 Kim JJ, Yang JS, Nottingham LK, Lee DJ, Lee M, Manson KH, Wyand MS, Boyer JD, Ugen KE, Weiner DB. Protection from immunodeficiency virus challenges in rhesus macaques by multicomponent DNA immunization. Virology. 285: 204-17. PMID 11437655 DOI: 10.1006/viro.2001.0958  0.32
2000 Sin JI, Kim J, Chattergoon M, Ayyavoo V, McCallus D, Ugen KE, Boyer JD, Weiner DB. Engineering of DNA vaccines using molecular adjuvant plasmids. Developments in Biologicals. 104: 187-98. PMID 11713819  0.32
2000 Boyer JD, Cohen AD, Ugen KE, Edgeworth RL, Bennett M, Shah A, Schumann K, Nath B, Javadian A, Bagarazzi ML, Kim J, Weiner DB. Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids. Aids (London, England). 14: 1515-22. PMID 10983638 DOI: 10.1097/00002030-200007280-00007  0.32
2000 Chattergoon MA, Kim JJ, Yang JS, Robinson TM, Lee DJ, Dentchev T, Wilson DM, Ayyavoo V, Weiner DB. Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis. Nature Biotechnology. 18: 974-9. PMID 10973219 DOI: 10.1038/79470  0.32
2000 Dickey C, Ziegner U, Agadjanyan MG, Srikantan V, Refaeli Y, Prabhu A, Sato A, Williams WV, Weiner DB, Ugen KE. Murine monoclonal antibodies biologically active against the amino region of HIV-1 gp120: isolation and characterization. Dna and Cell Biology. 19: 243-52. PMID 10798448 DOI: 10.1089/104454900314519  0.32
2000 Viveros M, Dickey C, Cotropia JP, Gevorkian G, Larralde C, Broliden K, Levi M, Burgess A, Cao C, Weiner DB, Agadjanyan MG, Ugen KE. Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41. Virology. 270: 135-45. PMID 10772986 DOI: 10.1006/viro.2000.0269  0.32
2000 Kim JJ, Yang JS, VanCott TC, Lee DJ, Manson KH, Wyand MS, Boyer JD, Ugen KE, Weiner DB. Modulation of antigen-specific humoral responses in rhesus macaques by using cytokine cDNAs as DNA vaccine adjuvants. Journal of Virology. 74: 3427-9. PMID 10708463 DOI: 10.1128/JVI.74.7.3427-3429.2000  0.32
2000 Boyer JD, Cohen AD, Vogt S, Schumann K, Nath B, Ahn L, Lacy K, Bagarazzi ML, Higgins TJ, Baine Y, Ciccarelli RB, Ginsberg RS, MacGregor RR, Weiner DB. Vaccination of seronegative volunteers with a human immunodeficiency virus type 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of beta-chemokines. The Journal of Infectious Diseases. 181: 476-83. PMID 10669329 DOI: 10.1086/315229  0.32
2000 MacGregor RR, Boyer JD, Ciccarelli RB, Ginsberg RS, Weiner DB. Safety and immune responses to a DNA-based human immunodeficiency virus (HIV) type I env/rev vaccine in HIV-infected recipients: follow-up data. The Journal of Infectious Diseases. 181: 406. PMID 10608800 DOI: 10.1086/315199  0.32
1999 Kim JJ, Nottingham LK, Tsai A, Lee DJ, Maguire HC, Oh J, Dentchev T, Manson KH, Wyand MS, Agadjanyan MG, Ugen KE, Weiner DB. Antigen-specific humoral and cellular immune responses can be modulated in rhesus macaques through the use of IFN-gamma, IL-12, or IL-18 gene adjuvants. Journal of Medical Primatology. 28: 214-23. PMID 10593488  0.32
1999 Boyer JD, Kim J, Ugen K, Cohen AD, Ahn L, Schumann K, Lacy K, Bagarazzi ML, Javadian A, Ciccarelli RB, Ginsberg RS, MacGregor RR, Weiner DB. HIV-1 DNA vaccines and chemokines. Vaccine. 17: S53-64. PMID 10506409  0.32
1999 Bagarazzi ML, Boyer JD, Javadian MA, Chattergoon MA, Shah AR, Cohen AD, Bennett MK, Ciccarelli RB, Ugen KE, Weiner DB. Systemic and mucosal immunity is elicited after both intramuscular and intravaginal delivery of human immunodeficiency virus type 1 DNA plasmid vaccines to pregnant chimpanzees. The Journal of Infectious Diseases. 180: 1351-5. PMID 10479171 DOI: 10.1086/314978  0.32
1999 Agadjanyan MG, Kim JJ, Trivedi N, Wilson DM, Monzavi-Karbassi B, Morrison LD, Nottingham LK, Dentchev T, Tsai A, Dang K, Chalian AA, Maldonado MA, Williams WV, Weiner DB. CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo. Journal of Immunology (Baltimore, Md. : 1950). 162: 3417-27. PMID 10092797  0.32
1999 Boyer JD, Chattergoon MA, Ugen KE, Shah A, Bennett M, Cohen A, Nyland S, Lacy KE, Bagarazzi ML, Higgins TJ, Baine Y, Ciccarelli RB, Ginsberg RS, MacGregor RR, Weiner DB. Enhancement of cellular immune response in HIV-1 seropositive individuals: A DNA-based trial. Clinical Immunology (Orlando, Fla.). 90: 100-7. PMID 9884357 DOI: 10.1006/clim.1998.4616  0.32
1999 Sin JI, Kim JJ, Boyer JD, Ciccarelli RB, Higgins TJ, Weiner DB. In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model. Journal of Virology. 73: 501-9. PMID 9847356  0.32
1998 Kim JJ, Trivedi NN, Wilson DM, Mahalingam S, Morrison L, Tsai A, Chattergoon MA, Dang K, Patel M, Ahn L, Boyer JD, Chalian AA, Schoemaker H, Kieber-Emmons T, Agadjanyan MA, ... Weiner DB, et al. Molecular and immunological analysis of genetic prostate specific antigen (PSA) vaccine. Oncogene. 17: 3125-35. PMID 9872328 DOI: 10.1038/sj.onc.1201736  0.32
1998 Boyer JD, Chattergoon M, Shah A, Ginsberg R, MacGregor RR, Weiner DB. HIV-1 DNA based vaccine induces a CD8 mediated cross-clade CTL response. Developments in Biological Standardization. 95: 147-53. PMID 9855425  0.32
1998 Sin JI, Kim JJ, Ugen KE, Ciccarelli RB, Higgins TJ, Weiner DB. Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes. European Journal of Immunology. 28: 3530-40. PMID 9842896 DOI: 10.1002/(SICI)1521-4141(199811)28:11<3530::AID-IMMU3530>3.0.CO;2-C  0.32
1998 Cohen AD, Boyer JD, Weiner DB. Modulating the immune response to genetic immunization. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 12: 1611-26. PMID 9837851  0.32
1998 Bagarazzi ML, Boyer JD, Ugen KE, Javadian MA, Chattergoon M, Shah A, Bennett M, Ciccarelli R, Carrano R, Coney L, Weiner DB. Safety and immunogenicity of HIV-1 DNA constructs in chimpanzees. Vaccine. 16: 1836-41. PMID 9795389 DOI: 10.1016/S0264-410X(98)00178-9  0.32
1998 Ugen KE, Nyland SB, Boyer JD, Vidal C, Lera L, Rasheid S, Chattergoon M, Bagarazzi ML, Ciccarelli R, Higgins T, Baine Y, Ginsberg R, Macgregor RR, Weiner DB. DNA vaccination with HIV-1 expressing constructs elicits immune responses in humans. Vaccine. 16: 1818-21. PMID 9795386 DOI: 10.1016/S0264-410X(98)00180-7  0.32
1998 Kim JJ, Nottingham LK, Sin JI, Tsai A, Morrison L, Oh J, Dang K, Hu Y, Kazahaya K, Bennett M, Dentchev T, Wilson DM, Chalian AA, Boyer JD, Agadjanyan MG, ... Weiner DB, et al. CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines. The Journal of Clinical Investigation. 102: 1112-24. PMID 9739045 DOI: 10.1172/JCI3986  0.32
1998 MacGregor RR, Boyer JD, Ugen KE, Lacy KE, Gluckman SJ, Bagarazzi ML, Chattergoon MA, Baine Y, Higgins TJ, Ciccarelli RB, Coney LR, Ginsberg RS, Weiner DB. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. The Journal of Infectious Diseases. 178: 92-100. PMID 9652427  0.32
1998 Chattergoon MA, Robinson TM, Boyer JD, Weiner DB. Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells. Journal of Immunology (Baltimore, Md. : 1950). 160: 5707-18. PMID 9637479  0.32
1998 Boyer J, Ugen K, Wang B, Chattergoon M, Tsai A, Merva M, Weiner DB. Induction of a TH1 type cellular immune response to the human immunodeficiency type 1 virus by in vivo DNA inoculation. Developments in Biological Standardization. 92: 169-74. PMID 9554272  0.32
1998 Kim JJ, Trivedi NN, Nottingham LK, Morrison L, Tsai A, Hu Y, Mahalingam S, Dang K, Ahn L, Doyle NK, Wilson DM, Chattergoon MA, Chalian AA, Boyer JD, Agadjanyan MG, ... Weiner DB, et al. Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens. European Journal of Immunology. 28: 1089-103. PMID 9541605 DOI: 10.1002/(SICI)1521-4141(199803)28:03<1089::AID-IMMU1089>3.0.CO;2-L  0.32
1998 Agadjanyan MG, Chattergoon MA, Petrushina I, Bennett M, Kim J, Ugen KE, Kieber-Emmons T, Weiner DB. Monoclonal antibodies define a cellular antigen involved in HTLV-I infection. Hybridoma. 17: 9-19. PMID 9523233  0.32
1998 Agadjanyan MG, Wang B, Nyland SB, Weiner DB, Ugen KE. DNA plasmid based vaccination against the oncogenic human T cell leukemia virus type 1. Current Topics in Microbiology and Immunology. 226: 175-92. PMID 9479842  0.32
1998 Bagarazzi ML, Boyer JD, Ayyavoo V, Weiner DB. Nucleic acid-based vaccines as an approach to immunization against human immunodeficiency virus type-1. Current Topics in Microbiology and Immunology. 226: 107-43. PMID 9479839 DOI: 10.1007/978-3-642-80475-5_8  0.32
1998 Koprowski H, Weiner DB. DNA vaccination/genetic vaccination. Current Topics in Microbiology and Immunology. 226: V-XIII. PMID 9479831  0.32
1997 Agadjanyan MG, Trivedi NN, Kudchodkar S, Bennett M, Levine W, Lin A, Boyer J, Levy D, Ugen KE, Kim JJ, Weiner DB. An HIV type 2 DNA vaccine induces cross-reactive immune responses against HIV type 2 and SIV. Aids Research and Human Retroviruses. 13: 1561-72. PMID 9430248  0.32
1997 Kim JJ, Weiner DB. DNA gene vaccination for HIV. Springer Seminars in Immunopathology. 19: 175-94. PMID 9406345 DOI: 10.1007/BF00870267  0.32
1997 Boyer JD, Ugen KE, Chattergoon M, Wang B, Shah A, Agadjanyan M, Bagarazzi ML, Javadian A, Carrano R, Coney L, Williams WV, Weiner DB. DNA vaccination as anti-human immunodeficiency virus immunotherapy in infected chimpanzees. The Journal of Infectious Diseases. 176: 1501-9. PMID 9395361  0.32
1997 Chattergoon M, Boyer J, Weiner DB. Genetic immunization: a new era in vaccines and immune therapeutics. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 11: 753-63. PMID 9271360  0.32
1997 Bagarazzi ML, Boyer JD, Javadian MA, Chattergoon M, Dang K, Kim G, Shah J, Wang B, Weiner DB. Safety and immunogenicity of intramuscular and intravaginal delivery of HIV-1 DNA constructs to infant chimpanzees. Journal of Medical Primatology. 26: 27-33. PMID 9271186  0.32
1997 Ugen KE, Boyer JD, Wang B, Bagarazzi M, Javadian A, Frost P, Merva MM, Agadjanyan MG, Nyland S, Williams WV, Coney L, Ciccarelli R, Weiner DB. Nucleic acid immunization of chimpanzees as a prophylactic/immunotherapeutic vaccination model for HIV-1: prelude to a clinical trial. Vaccine. 15: 927-30. PMID 9234550 DOI: 10.1016/S0264-410X(96)00254-X  0.32
1997 Kim JJ, Ayyavoo V, Bagarazzi ML, Chattergoon M, Boyer JD, Wang B, Weiner DB. Development of a multicomponent candidate vaccine for HIV-1. Vaccine. 15: 879-83. PMID 9234538 DOI: 10.1016/S0264-410X(96)00260-5  0.32
1997 Wang B, Dang K, Agadjanyan MG, Srikantan V, Li F, Ugen KE, Boyer J, Merva M, Williams WV, Weiner DB. Mucosal immunization with a DNA vaccine induces immune responses against HIV-1 at a mucosal site. Vaccine. 15: 821-5. PMID 9234524 DOI: 10.1016/S0264-410X(96)00259-9  0.32
1997 Kim JJ, Bagarazzi ML, Trivedi N, Hu Y, Kazahaya K, Wilson DM, Ciccarelli R, Chattergoon MA, Dang K, Mahalingam S, Chalian AA, Agadjanyan MG, Boyer JD, Wang B, Weiner DB. Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes. Nature Biotechnology. 15: 641-6. PMID 9219266 DOI: 10.1038/nbt0797-641  0.32
1997 Boyer JD, Ugen KE, Wang B, Agadjanyan M, Gilbert L, Bagarazzi ML, Chattergoon M, Frost P, Javadian A, Williams WV, Refaeli Y, Ciccarelli RB, McCallus D, Coney L, Weiner DB. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nature Medicine. 3: 526-32. PMID 9142121  0.32
1997 Mahalingam S, MacDonald B, Ugen KE, Ayyavoo V, Agadjanyan MG, Williams WV, Weiner DB. In vitro and in vivo tumor growth suppression by HIV-1 Vpr. Dna and Cell Biology. 16: 137-43. PMID 9052734  0.32
1997 Kim JJ, Ayyavoo V, Bagarazzi ML, Chattergoon MA, Dang K, Wang B, Boyer JD, Weiner DB. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. Journal of Immunology (Baltimore, Md. : 1950). 158: 816-26. PMID 8992999  0.32
1997 Ugen KE, Srikantan V, Goedert JJ, Nelson RP, Williams WV, Weiner DB. Vertical transmission of human immunodeficiency virus type 1: seroreactivity by maternal antibodies to the carboxy region of the gp41 envelope glycoprotein. The Journal of Infectious Diseases. 175: 63-9. PMID 8985197  0.32
1996 Monfardini C, Kieber-Emmons T, VonFeldt JM, Godillot AP, Voet D, Weiner DB, Williams WV. Rational design, analysis, and potential utility of GM-CSF antagonists. Proceedings of the Association of American Physicians. 108: 420-31. PMID 8956365  0.32
1996 Boyer JD, Wang B, Ugen KE, Agadjanyan M, Javadian A, Frost P, Dang K, Carrano RA, Ciccarelli R, Coney L, Williams WV, Weiner DB. In vivo protective anti-HIV immune responses in non-human primates through DNA immunization. Journal of Medical Primatology. 25: 242-50. PMID 8892046  0.32
1996 Cotropia J, Ugen KE, Kliks S, Broliden K, Broliden PA, Hoxie JA, Srikantan V, Williams WV, Weiner DB. A human monoclonal antibody to HIV-1 gp41 with neutralizing activity against diverse laboratory isolates. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association. 12: 221-32. PMID 8673526  0.32
1996 Monfardini C, Kieber-Emmons T, Voet D, Godillot AP, Weiner DB, Williams WV. Rational design of granulocyte-macrophage colony-stimulating factor antagonist peptides. The Journal of Biological Chemistry. 271: 2966-71. PMID 8621688 DOI: 10.1074/jbc.271.6.2966  0.32
1995 Monfardini C, Kieber-Emmons T, VonFeldt JM, O'Malley B, Rosenbaum H, Godillot AP, Kaushansky K, Brown CB, Voet D, McCallus DE. Recombinant antibodies in bioactive peptide design. The Journal of Biological Chemistry. 270: 6628-38. PMID 7896802 DOI: 10.1074/jbc.270.12.6628  0.32
1995 Wang B, Merva M, Dang K, Ugen KE, Williams WV, Weiner DB. Immunization by direct DNA inoculation induces rejection of tumor cell challenge. Human Gene Therapy. 6: 407-18. PMID 7612698 DOI: 10.1089/hum.1995.6.4-407  0.32
1994 Agadjanyan MG, Ugen KE, Wang B, Williams WV, Weiner DB. Identification of an 80-kilodalton membrane glycoprotein important for human T-cell leukemia virus type I and type II syncytium formation and infection Journal of Virology. 68: 485-493. PMID 8254759  0.32
1994 Williams WV, VonFeldt JM, Rosenbaum H, Ugen KE, Weiner DB. Molecular cloning of a soluble form of the granulocyte-macrophage colony-stimulating factor receptor alpha chain from a myelomonocytic cell line. Expression, biologic activity, and preliminary analysis of transcript distribution. Arthritis and Rheumatism. 37: 1468-78. PMID 7945472 DOI: 10.1002/art.1780371010  0.32
1994 Srikantan V, Wang B, Satre MA, Ugen KE, Dang K, Scales F, Godillot AP, Williams WV, Weiner DB. Cloning and biological characterization of human single-chain Fv fragments that mediate neutralization of HIV-1 Aids. 8: 1525-1532. PMID 7848589  0.32
1994 Ugen KE, Von Feldt JM, Weiner DB, Ziegner UHM. Diagnosis and prediction of pediatric HIV-1 infection and AIDS: Current status Journal of Clinical Laboratory Analysis. 8: 309-314. PMID 7807285  0.32
1994 Eaton AM, Ugen KE, Weiner DB, Wildes T, Levy JA. An anti-gp41 human monoclonal antibody that enhances HIV-1 infection in the absence of complement. Aids Research and Human Retroviruses. 10: 13-8. PMID 7514015  0.32
1993 Wang B, Ugen KE, Srikantan V, Agadjanyan MG, Dang K, Refaeli Y, Sato AI, Boyer J, Williams WV, Weiner DB. Gene inoculation generates immune responses against human immunodeficiency virus type 1 Proceedings of the National Academy of Sciences of the United States of America. 90: 4156-4160. PMID 8483929  0.32
1993 Bhat S, Mettus RV, Reddy EP, Ugen KE, Srikanthan V, Williams WV, Weiner DB. The galactosyl ceramide/sulfatide receptor binding region of HIV-1 gp120 maps to amino acids 206-275 Aids Research and Human Retroviruses. 9: 175-181. PMID 8457384  0.32
1993 Wang B, Agadjanyan MG, Srikantan V, Ugen KE, Hall W, Kaplan MH, Dang K, Williams WV, Weiner DB. Molecular cloning, expression, and biological characterization of an HTLV- II envelope glycoprotein: HIV-1 expression is permissive for HTLV-II-induced cell fusion Aids Research and Human Retroviruses. 9: 849-860. PMID 8257634  0.32
1992 Laczkó I, Hollósi M, Ürge L, Ugen KE, Weiner DB, Mantsch HH, Thurin J, Ötvös L. Synthesis and conformational studies of N-glycosylated analogues of the HIV-1 principal neutralizing determinant Biochemistry. 31: 4282-4288. PMID 1567873  0.32
1992 Williams WV, Callegari P, Freundlich B, Keenan G, Eldridge D, Shin H, Kreitman M, McCallus D, Weiner DB. Molecular diagnosis of Borrelia burgdorferi infection (Lyme disease). Dna and Cell Biology. 11: 207-13. PMID 1567553 DOI: 10.1089/DNA.1992.11.207  0.32
1992 Ugen KE, McCallus DE, Von Feldt JM, Williams WV, Greene MI, Weiner DB. Ocular tissue involvement in HIV infection: Immunological and pathological aspects Immunologic Research. 11: 141-153. PMID 1431423 DOI: 10.1007/BF02918619  0.32
1992 Von Feldt JM, Kieber-Emmons T, Weiner DB, Ugen KE, Williams WV. Molecular structure and granulocyte/macrophage colony-stimulating factor activity Dna and Cell Biology. 11: 183-191. PMID 1373625  0.32
1992 Osther K, Wiik A, Black F, Skinhøj P, Kellermann G, Ugen KE, Williams WV, Weiner DB. PASSHIV-1 treatment of patients with HIV-1 infection. A preliminary report of a Phase I trial of hyperimmune porcine immunoglobulin to HIV-1 Aids. 6: 1457-1464. PMID 1362878  0.32
1992 McCallus DE, Ugen KE, Sato AI, Williams WV, Weiner DB. Construction of a recombinant bacterial human CD4 expression system producing a bioactive CD4 molecule Viral Immunology. 5: 163-172. PMID 1319711  0.32
1991 Osther K, Kellermann G, Ugen KE, Williams WV, Weiner DB. Protective humoral immune responses to the human immunodeficiency virus induced in immunized pigs: A possible source of therapeutic immunoglobulin preparations Hybridoma. 10: 673-683. PMID 1816071  0.32
1989 Romano C, Williams WV, Fischberg DJ, Cocero N, Weiner DB, Greene MI, Molinoff PB. Subtype-selective immunoprecipitation of the beta 2-adrenergic receptor. Journal of Neurochemistry. 53: 362-9. PMID 2545815 DOI: 10.1111/j.1471-4159.1989.tb07343.x  0.32
1988 Weiner DB, Siegel RM, Williams WV, Greene MI. Lymphocyte networks and soluble factors in immunologic suppression Clinical Immunology Newsletter. 9: 184-188. DOI: 10.1016/0197-1859(88)90074-X  0.32
Show low-probability matches.